1. D

    Masitinib phase 2-3 positive final results

    AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease Primary analysis is a success and confirms interim analysis Company to host webcast on masitinib in ALS AB Science SA...
  2. D

    Masitinib phase 3 !

    PARIS, April 4, 2016 -- AB Science Announces Positive Interim Results from Phase 3 Trial of Masitinib in Amyotrophic Lateral Sclerosis (ALS) (also known as Lou Gehrig's disease) Company to Host Webcast on Masitinib in ALS in the Coming Days AB Science SA (NYSE Euronext - FR0010557264 - AB), a...
  3. A

    Completeley confused and deppressed !

    This is the first time i have written here, my mom was diagnosed in september 2011, My mom is a very independent woman, and to today i can not find the courage to confront her with her diagnose, she does not know what this disease is just like i didnt either, but the more i look and find out and...